Yale Chemists Use Electricity to Turn CO2, Nitrite, and Aldehydes into Valuable Amino Acids

Researchers at Yale University have developed a two-step electrochemical process that converts carbon dioxide, nitrite, and aromatic aldehydes into arylglycine amino acids, which are key building blocks for antibiotics and other pharmaceuticals. The method uses electricity to drive reductive carboxylation, avoiding toxic reagents like cyanide and harsh conditions common in traditional synthesis. In a model reaction, they achieved 81% Faradaic efficiency for phenylglycine production, with 84% conversion of the starting aldehyde. The process integrates two electrochemical steps: first, nitrite is reduced to hydroxylamine, which condenses with an aldehyde to form an oxime; second, the oxime undergoes reductive carboxylation with CO2 under Lewis acid catalysis. The team mapped the rate-determining step and demonstrated broad substrate scope, including heteroaromatic aldehydes. This approach not only fixes CO2 into high-value molecules but also repurposes nitrite from waste streams, hinting at a circular nitrogen economy. While still at lab scale, the high Faradaic efficiency and use of inexpensive feedstocks suggest potential for industrial scaling. The dual benefit of consuming a greenhouse gas and upgrading a pollutant into pharmaceutical raw material aligns with sustainable chemistry goals. If electricity comes from renewable sources, this route could contribute to decarbonizing the chemical and pharma sectors.